BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27144281)

  • 1. MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis.
    Boehme SA; Franz-Bacon K; DiTirro DN; Ly TW; Bacon KB
    PLoS One; 2016; 11(5):e0154874. PubMed ID: 27144281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis.
    Jones IC; Espindola MS; Narayanan R; Coelho AL; Habiel DM; Boehme SA; Ly TW; Bacon KB; Hogaboam CM
    Sci Rep; 2019 Dec; 9(1):19796. PubMed ID: 31875033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
    Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
    Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein tyrosine phosphatase-α amplifies transforming growth factor-β-dependent profibrotic signaling in lung fibroblasts.
    Aschner Y; Nelson M; Brenner M; Roybal H; Beke K; Meador C; Foster D; Correll KA; Reynolds PR; Anderson K; Redente EF; Matsuda J; Riches DWH; Groshong SD; Pozzi A; Sap J; Wang Q; Rajshankar D; McCulloch CAG; Zemans RL; Downey GP
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L294-L311. PubMed ID: 32491951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
    Mackinnon AC; Gibbons MA; Farnworth SL; Leffler H; Nilsson UJ; Delaine T; Simpson AJ; Forbes SJ; Hirani N; Gauldie J; Sethi T
    Am J Respir Crit Care Med; 2012 Mar; 185(5):537-46. PubMed ID: 22095546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
    Zhu L; Fu X; Chen X; Han X; Dong P
    Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial Deletion of Sulf2 Exacerbates Bleomycin-Induced Lung Injury, Inflammation, and Mortality.
    Yue X
    Am J Respir Cell Mol Biol; 2017 Nov; 57(5):560-569. PubMed ID: 28657777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
    Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib.
    Zhang Y; Jones KD; Achtar-Zadeh N; Green G; Kukreja J; Xu B; Wolters PJ
    Histopathology; 2019 Jan; 74(2):341-349. PubMed ID: 30152895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fyn-kinase and caveolin-1 in the alveolar epithelial junctional adherence complex contribute to the early stages of pulmonary fibrosis.
    Menzel V; Ziegler M; Hante N; Sake JA; Santos-Martinez MJ; Ehrhardt C; Kasper M; Barth K
    Eur J Pharm Sci; 2022 Aug; 175():106236. PubMed ID: 35710078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipids in pulmonary fibrosis.
    Huang LS; Natarajan V
    Adv Biol Regul; 2015 Jan; 57():55-63. PubMed ID: 25446881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
    Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
    Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
    J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nintedanib modulates surfactant protein-D expression in A549 human lung epithelial cells via the c-Jun N-terminal kinase-activator protein-1 pathway.
    Kamio K; Usuki J; Azuma A; Matsuda K; Ishii T; Inomata M; Hayashi H; Kokuho N; Fujita K; Saito Y; Miya T; Gemma A
    Pulm Pharmacol Ther; 2015 Jun; 32():29-36. PubMed ID: 25843005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
    Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
    J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
    Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAP3K19 Is Overexpressed in COPD and Is a Central Mediator of Cigarette Smoke-Induced Pulmonary Inflammation and Lower Airway Destruction.
    Boehme SA; Franz-Bacon K; Ludka J; DiTirro DN; Ly TW; Bacon KB
    PLoS One; 2016; 11(12):e0167169. PubMed ID: 27935962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment.
    Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; Boomershine CS; Ortiz C; Sherrill TP; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
    Am J Physiol Lung Cell Mol Physiol; 2011 Jun; 300(6):L887-97. PubMed ID: 21441353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis.
    Ohta H; Chiba S; Ebina M; Furuse M; Nukiwa T
    Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(2):L193-205. PubMed ID: 22003091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.